Temsirolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well temsirolimus works in treating patients with
relapsed or refractory multiple myeloma. Drugs used in chemotherapy such as temsirolimus work
in different ways to stop cancer cells from dividing so they stop growing or die.